Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole in Combination With IL-23 Therapy for Crohn's Disease
NCT06274554Phase 3Recruiting
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2024
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluconazole in Crohn's disease, sponsored by Weill Cornell Medicine. Started Oct 2024; status: recruiting.
02
Drugs
fluconazole
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT06274554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06274554.